Novartis Wants To Question Bone Patients' Doctors
Locked in a product liability war over its bone cancer drugs, Novartis Pharmaceuticals Corp. is seeking court permission to engage in talks with the plaintiffs' treating and prescribing physicians in an...To view the full article, register now.
Already a subscriber? Click here to view full article